TALARIS THERAPEUTICS INC (TALS)

US87410C1045 - Common Stock

2.72  -0.02 (-0.73%)

After market: 2.75 +0.03 (+1.1%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to TALS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.4. This target is 650% above the current price.
TALS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TALS.
In the previous month the buy percentage consensus was at a similar level.
TALS was analyzed by 6 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 2.7220.2020.4020.4021.00 - 642.65% 650.00% 650.00% 672.06%
Up and Down Grades
Date Firm Action Rating
2023-04-17 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-02-23 Morgan Stanley Maintains Equal-Weight
2023-01-30 HC Wainwright & Co. Reiterate Buy
2022-10-24 HC Wainwright & Co. Maintains Buy
2022-10-20 SVB Leerink Maintains Market Perform
2022-10-20 HC Wainwright & Co. Initiate Buy
2022-09-09 Morgan Stanley Maintains Equal-Weight
2022-07-05 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-07-01 SVB Leerink Downgrade Outperform -> Market Perform
2022-05-24 Morgan Stanley Maintains Overweight
2022-05-13 SVB Leerink Maintains Outperform
2021-11-12 SVB Leerink Maintains Outperform
2021-06-01 Guggenheim Initiate Buy
2021-06-01 SVB Leerink Initiate Outperform
2021-06-01 Evercore ISI Group Initiate Outperform
2021-06-01 Morgan Stanley Initiate Overweight